Sherwin-Williams (NYSE:SHW – Get Free Report) was upgraded by DA Davidson to a “strong-buy” rating in a note issued to investors on Monday,Zacks.com reports.
A number of other research firms have also commented on SHW. BMO Capital Markets reissued an “outperform” rating and issued a $405.00 target price (up from $400.00) on shares of Sherwin-Williams in a report on Wednesday, July 29th. Guggenheim assumed coverage on Sherwin-Williams in a research report on Monday, August 3rd. They set a “buy” rating and a $400.00 price objective on the stock. Berenberg Bank set a $380.00 price objective on Sherwin-Williams in a research report on Monday, June 8th. Evercore reiterated an “outperform” rating on shares of Sherwin-Williams in a report on Friday, May 8th. Finally, JPMorgan Chase & Co. boosted their target price on Sherwin-Williams from $365.00 to $380.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 29th. One equities research analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating and seven have issued a Hold rating to the company. Based on data from MarketBeat.com, Sherwin-Williams has an average rating of “Moderate Buy” and an average target price of $386.29.
View Our Latest Report on Sherwin-Williams
Sherwin-Williams Price Performance
Sherwin-Williams (NYSE:SHW – Get Free Report) last announced its quarterly earnings data on Tuesday, July 28th. The specialty chemicals company reported $3.70 earnings per share for the quarter, topping analysts’ consensus estimates of $3.52 by $0.18. The company had revenue of $6.79 billion during the quarter, compared to analyst estimates of $6.60 billion. Sherwin-Williams had a net margin of 11.01% and a return on equity of 67.97%. The firm’s revenue for the quarter was up 7.5% on a year-over-year basis. During the same period in the previous year, the business earned $3.38 EPS. Sherwin-Williams has set its FY 2026 guidance at 11.800-12.200 EPS. As a group, equities research analysts anticipate that Sherwin-Williams will post 12.08 earnings per share for the current fiscal year.
Insider Buying and Selling at Sherwin-Williams
In other news, insider Karl J. Jorgenrud sold 7,886 shares of the stock in a transaction on Friday, August 7th. The stock was sold at an average price of $368.30, for a total transaction of $2,904,413.80. Following the transaction, the insider directly owned 11,944 shares of the company’s stock, valued at $4,398,975.20. This represents a 39.77% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, insider Justin T. Binns sold 13,500 shares of the firm’s stock in a transaction on Monday, August 17th. The stock was sold at an average price of $352.70, for a total value of $4,761,450.00. Following the completion of the transaction, the insider owned 21,937 shares in the company, valued at approximately $7,737,179.90. This trade represents a 38.10% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 0.23% of the stock is owned by corporate insiders.
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently bought and sold shares of SHW. Brighton Jones LLC raised its position in Sherwin-Williams by 73.6% in the fourth quarter. Brighton Jones LLC now owns 1,545 shares of the specialty chemicals company’s stock worth $525,000 after acquiring an additional 655 shares during the period. Empowered Funds LLC increased its stake in shares of Sherwin-Williams by 11.2% in the 1st quarter. Empowered Funds LLC now owns 6,236 shares of the specialty chemicals company’s stock worth $2,178,000 after purchasing an additional 626 shares in the last quarter. Jump Financial LLC purchased a new stake in shares of Sherwin-Williams in the 2nd quarter worth $1,210,000. Sei Investments Co. raised its holdings in Sherwin-Williams by 43.6% in the 2nd quarter. Sei Investments Co. now owns 196,915 shares of the specialty chemicals company’s stock worth $67,612,000 after purchasing an additional 59,831 shares during the period. Finally, Glenview Trust co raised its holdings in Sherwin-Williams by 4.8% in the 2nd quarter. Glenview Trust co now owns 3,249 shares of the specialty chemicals company’s stock worth $1,116,000 after purchasing an additional 148 shares during the period. 77.67% of the stock is owned by hedge funds and other institutional investors.
About Sherwin-Williams
Sherwin-Williams (NYSE: SHW) is a global manufacturer and distributor of paints, coatings and related products. Founded in 1866 and headquartered in Cleveland, Ohio, the company supplies a broad range of coatings for residential, commercial and industrial applications. Its product offering includes architectural paints and stains, industrial and protective coatings, automotive finishes, and a variety of sundry products such as primers, sealants and specialty treatments used by professionals and consumers.
The company sells through multiple channels, including a large network of company-operated retail paint stores that serve professional contractors and do-it-yourself consumers, as well as through distributors and mass retailers.
Featured Stories
- Five stocks we like better than Sherwin-Williams
- Marzetti Stock Confirms Reversal on Earnings Strength, Dividend Growth
- Pathward’s Credit Scare Tests Its Comeback Story
- Wiring the AI Boom: Rumble’s $13.7B Pivot
- StoneX: Too Far Too Fast?
Receive News & Ratings for Sherwin-Williams Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sherwin-Williams and related companies with MarketBeat.com's FREE daily email newsletter.
